Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-12

Clinical Trial Update: Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Coristina D to Resfenol for symptomatic treatment of the common cold is underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coristina D
  • Resfenol

Snippet

Sponsor: Brainfarma Industria Química e Farmacêutica S/A | Conditions: Cold | Phase 3 | Status: UNKNOWN